Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Aqueous soluble vascular endothelial growth factor receptor-2 in macular edema with branch retinal vein occlusion.

Noma H, Mimura T.

Curr Eye Res. 2013 Dec;38(12):1288-90. doi: 10.3109/02713683.2013.821135. Epub 2013 Aug 23.

PMID:
23972086
2.

Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.

Noma H, Funatsu H, Mimura T, Eguchi S, Hori S.

Am J Ophthalmol. 2011 Oct;152(4):669-677.e1. doi: 10.1016/j.ajo.2011.04.006. Epub 2011 Jul 2.

PMID:
21726846
3.

Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.

Noma H, Mimura T, Yasuda K, Shimura M.

Invest Ophthalmol Vis Sci. 2014 Jun 3;55(6):3878-85. doi: 10.1167/iovs.14-13961.

PMID:
24894397
4.

Association of inflammatory factors with macular edema in branch retinal vein occlusion.

Noma H, Mimura T, Eguchi S.

JAMA Ophthalmol. 2013 Feb;131(2):160-5. doi: 10.1001/2013.jamaophthalmol.228.

PMID:
23411880
5.

Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.

Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK.

Am J Ophthalmol. 2005 Aug;140(2):256-61.

PMID:
16086947
6.

Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.

Noma H, Mimura T, Yasuda K, Shimura M.

Invest Ophthalmol Vis Sci. 2015 Jan 29;56(2):1122-8. doi: 10.1167/iovs.14-15789.

PMID:
25634982
7.

Vascular endothelial growth factor receptor-2 in macular oedema with retinal vein occlusion.

Noma H, Funatsu H, Mimura T, Eguchi S.

Ophthalmic Res. 2012;48(1):56-8. doi: 10.1159/000336020. Epub 2012 Mar 9.

PMID:
22415022
8.

Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.

Kim JH, Shin JP, Kim IT, Park DH.

Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):6-11. doi: 10.1167/iovs.15-18304.

PMID:
26746013
9.

Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.

Lim JW.

Ophthalmologica. 2011;225(3):150-4. doi: 10.1159/000322364. Epub 2010 Dec 9.

PMID:
21150231
10.

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion.

Noma H, Mimura T, Shimada K.

BMC Ophthalmol. 2014 May 18;14:67. doi: 10.1186/1471-2415-14-67.

11.

POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION.

Noma H, Mimura T, Yasuda K, Shimura M.

Retina. 2016 Sep;36(9):1718-25. doi: 10.1097/IAE.0000000000000983.

PMID:
26866529
12.

Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion.

Okunuki Y, Usui Y, Katai N, Kezuka T, Takeuchi M, Goto H, Wakabayashi Y.

Am J Ophthalmol. 2011 Apr;151(4):610-616.e1. doi: 10.1016/j.ajo.2010.09.030. Epub 2011 Jan 22.

PMID:
21257152
13.

Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.

Park SP, Ahn JK, Mun GH.

Retina. 2010 Feb;30(2):281-6. doi: 10.1097/IAE.0b013e3181b9f153.

PMID:
19881397
14.

Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.

Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK.

Eye (Lond). 2008 Jan;22(1):42-8. Epub 2006 Jul 7.

PMID:
16826241
15.

Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion.

Noma H, Funatsu H, Mimura T, Harino S, Hori S.

Eur J Ophthalmol. 2010 Mar-Apr;20(2):402-9.

16.

Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.

Noma H, Funatsu H, Mimura T, Harino S, Hori S.

Ophthalmology. 2009 Jan;116(1):87-93. doi: 10.1016/j.ophtha.2008.09.034.

PMID:
19118700
17.

Proteomic analysis of aqueous humor from patients with branch retinal vein occlusion-induced macular edema.

Yao J, Chen Z, Yang Q, Liu X, Chen X, Zhuang M, Liu Q.

Int J Mol Med. 2013 Dec;32(6):1421-34. doi: 10.3892/ijmm.2013.1509. Epub 2013 Sep 25.

PMID:
24068204
18.

Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study.

Noma H, Funatsu H, Mimura T, Shimada K.

J Inflamm (Lond). 2010 Aug 26;7:44. doi: 10.1186/1476-9255-7-44.

19.

Pentraxin 3 and other inflammatory factors in central retinal vein occlusion and macular edema.

Noma H, Mimura T, Masahara H, Shimada K.

Retina. 2014 Feb;34(2):352-9. doi: 10.1097/IAE.0b013e3182993d74.

PMID:
23842103
20.

Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema.

Noma H, Funatsu H, Mimura T, Harino S, Eguchi S, Hori S.

Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1559-65. doi: 10.1007/s00417-010-1486-7. Epub 2010 Aug 17.

PMID:
20714746

Supplemental Content

Support Center